T cells modulate neutrophil-dependent acute renal failure during endotoxemia: Critical role for CD28

Journal of the American Society of Nephrology

Volumn 16, Issue 3, 2005, Pages 720-728

  Singbartl, Kai ^a   Bockhorn, Susanne Große ^a   Zarbock, Alexander ^a   Schmolke, Mirco ^a   Van Aken, Hugo ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CHEMOKINE; GENE PRODUCT; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KIDNEY FAILURE; MOUSE; NEUTROPHIL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE; ACUTE KIDNEY FAILURE; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CELL MOTION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KIDNEY; MALE; MOUSE MUTANT; PATHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD28; CELL MOVEMENT; CHEMOKINES; ENDOTOXEMIA; GENE EXPRESSION; KIDNEY; KIDNEY FAILURE, ACUTE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEUTROPHILS; T-LYMPHOCYTES;

EID: 20544464270     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004050381     Document Type: Article

References (44)

1. Liano F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int 66: S16-S24, 1998
2. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA: Leukocyte extravasation: Chemokine transport and presentation by the endothelium. Blood 100: 3853-3860, 2002
3. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150, 2003
4. Brealey DA, Karyampudi S, Jaques TS, Novelli M, Stidwill R, Taylor V, Smolenski RT, Singer M: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286: R491-R497
5. Cohen J: The immunopathogenesis of sepsis. Nature 420: 885-891, 2002
6. Beutler B, Hoebe K, Du X, Ulevitch RJ: How we detect microbes and respond to them: The Toll-like receptors and their transducers. J Leukoc Biol 74: 479-485, 2003
7. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383: 787-793, 1996
8. Opal SM, DePalo VA: Anti-inflammatory cytokines. Chest 117: 1162-1172, 2000
9. Margulies DH: CD28, costimulator or agonist receptor? J Exp Med 197: 949, 2003
10. Acuto O, Mise-Omata S, Mangino G, Michel F: Molecular modifiers of T cell antigen receptor triggering threshold: The mechanism of CD28 costimulatory receptor. Immunol Rev 192: 21-31, 2003
11. Mattern T, Thanhauser A, Reiling N, Toellner KM, Duchrow M, Kusumoto S, Rietschel ET, Ernst M, Brade H, Flad HD: Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol 153: 2996-3004, 1994
12. Mattern T, Flad HD, Brade L, Rietschel ET, Ulmer AJ: Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol 160: 3412-3418, 1998
13. Kane LP, Lin J, Weiss A: It's all relative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol 23: 413-420, 2002
14. Michel F, Mangino G, Attal-Bonnefoy G, Tuosto L, Alcover A, Roumier A, Olive D, Acuto O: CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J Immunol 165: 3820-3829, 2000
15. Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO: Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci U S A 99: 11796-11801, 2002
16. Carreno BM, Collins M: The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20: 29-53, 2002
17. Kondo S, Kooshesh F, Wang B, Fujisawa H, Sauder DN: Contribution of the CD28 molecule to allergic and irritant-induced skin reactions in CD28 -/- mice. J Immunol 157: 4822-4829, 1996
18. Via CS, Rus V, Nguyen P, Linsley P, Gause WC: Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J Immunol 157: 4258-4267, 1996
19. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG: Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 192: 681-694, 2000
20. Okazaki T, Nakao A, Nakano H, Takahashi F, Takahashi K, Shimozato O, Takeda K, Yagita H, Okumura K: Impairment of bleomycin-induced lung fibrosis in CD28-deficient mice. J Immunol 167: 1977-1981, 2001
21. Krinzman SJ, De Sanctis GT, Cernadas M, Mark D, Wang Y, Listman J, Kobzik L, Donovan C, Nassr K, Katona I, Christiani DC, Perkins DL, Finn PW: Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 98: 2693-2699, 1996
22. Wang R, Fang Q, Zhang L, Radvany L, Sharma A, Noben-Trauth N, Mills GB, Shi Y: CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression. J Immunol 158: 2856-2861, 1997
23. Kano M, Bashuda H, Yagita H, Okumura K, Morishita Y: A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice. Transplantation 65: 837-843, 1998
24. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106: 551-559, 2000
25. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612, 1993
26. Singbartl K, Ley K: Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 28: 2507-2514, 2000
27. Singbartl K, Green SA, Ley K: Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 14: 48-54, 2000
28. Singbartl K, Forlow SB, Ley K: Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute post-ischemic renal failure. FASEB J 15: 2337-2344, 2001
29. Jones M, Cordell JL, Beyers AD, Tse AG, Mason DY: Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. J Immunol 150: 5429-5435, 1993
30. Holtappels R, Podlech J, Geginat G, Steffens HP, Thomas D, Reddehase MJ: Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J Virol 72: 7201-7212, 1998
31. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168: 5817-5823, 2002
32. Hayashi H, Imanishi N, Ohnishi M, Tojo SJ: Sialyl Lewis X and anti-P-selectin antibody attenuate lipopolysaccharide-induced acute renal failure in rabbits. Nephron 87: 352-360, 2001
33. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ: Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172: 2629-2635, 2004
34. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290, 2001
35. Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H: Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285: F87-F94, 2003
36. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1 (Kim-1): A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 286: F552-F563, 2004
37. King AG, Johanson K, Frey CL, DeMarsh PL, White JR, McDevitt P, McNulty D, Balcarek J, Jonak ZL, Bhatnagar PK, Pelus LM: Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. J Immunol 164: 3774-3782, 2000
38. De Vriese AS: Prevention and treatment of acute renal failure in sepsis. J Am Soc Nephrol 14: 792-805, 2003
39. Borish LC, Steinke JW: 2. Cytokines and chemokines. J Allergy Clin Immunol 111: S460-S475, 2003
40. Shanley TP, Vasi N, Denenberg A: Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 12: 1054-1064, 2000
41. Ajuebor MN, Das AM, Virag L, Szabo C, Perretti M: Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun 255: 279-282, 1999
42. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA: Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 162: 4928-4937, 1999
43. Miura M, Morita K, Kobayashi H, Hamilton TA, Burdick MD, Strieter RM, Fairchild RL: Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 167: 3494-3504, 2001
44. Chen L, Sendo F: Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria. Parasitol Int 50: 139-143, 2001